Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL Infiltration vs TAP Block in C-Section
NCT03377595Phase 4Withdrawn
- Sponsor
- University of Minnesota
- Start
- Jul 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain, sponsored by University of Minnesota. Planned start Jul 2019; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03377595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03377595.